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Purpose. People with obesity, diabetes, and peripheral neuropathy have high levels of intermuscular adipose tissue (IMAT) volume
which has been inversely related to physical function. We determined if IMAT is muscle specific, if calf IMAT is diﬀerent between
a healthy obese group (HO), a group with diabetes mellitus (D), and a group with diabetes mellitus and peripheral neuropathy
(DN), and if IMAT volume or the ratio of IMAT/muscle volume is related to physical function in these groups. Methods. 10
healthy obese people, 11 with type 2 diabetes, 24 with diabetes and peripheral neuropathy, had assessments of muscle morphology,
physical function and muscle performance. Results. The gastrocnemius muscle had a higher ratio of IMAT/muscle volume than
any other muscle or compartment. There were no diﬀerences between groups in calf muscle or IMAT volumes. Calf IMAT was
inversely related to physical performance on the 6-minute walk test (r = −0.47) and physical performance test (r = −0.36).
IMAT/muscle volume was inversely related to physical performance (PPT, r = −0.44; 6 MW r = −0.48; stair power, r = −0.30).
Conclusions. IMAT accumulation varies in calf muscles, is highest in the gastrocnemius muscle, and is associated with poor physical
performance.

1. Introduction
Previous research has shown that people with obesity,
diabetes, and peripheral neuropathy have significantly greater amounts of intermuscular adipose tissue (IMAT) in the
calf compared to a nonobese control group and that this
calf IMAT was associated with poor physical performance
[1]. The unique contributions of obesity, diabetes, and
diabetes in combination with peripheral neuropathy to the
amount of IMAT in skeletal muscle, however, are not clear.
In addition, the relationship between calf IMAT and physical
performance is not clear in these groups. IMAT is defined as
the visible adipose tissue beneath muscle fascia and between
muscle groups [2, 3]. IMAT in the thigh has been linked to
insulin resistance and has been described as a unique adipose
tissue depot that is similar to visceral adipose tissue in its
risks for metabolic impairment [4–6], but little is known
about IMAT in the calf muscles. Previous investigators [5, 6]
have shown that IMAT is linked to insulin resistance and
that denervation [7] can also contribute to fat infiltration in

muscle, but it is unclear how the combination of obesity, diabetes, and peripheral neuropathy impacts IMAT infiltration.
It is also unknown whether calf IMAT accumulation is
muscle or muscle compartment specific, that is, whether
one muscle or a group of muscles tends to have more
IMAT than others. Identifying preferential diﬀerences in
IMAT accumulation may help to understand the purpose
of IMAT. Muscles in the calf have diﬀerent distributions
of fast twitch and slow twitch fibers. For example, the
gastrocnemius muscle is considered predominantly a fast
twitch muscle and is used more for large force production,
while the soleus muscle is considered more slow twitch and
is a postural muscle that is better suited for using lipids
as a fuel source [8]. It has been shown in animal models
that there is a diﬀerence in fatty acid transport in muscles
with diﬀerent fiber type distributions (type I/red muscles
are more oxidative than type II/white) and that fatty acid
transport and triacylglycerides in muscle are impacted by
insulin resistance and diabetes [9]. Additionally, increased
triglyceride storage has been shown in the type I fibers of
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the soleus in obese rats [10]. It is unknown in humans whether muscles with diﬀerent “predominance” of fiber types are
targeted by IMAT infiltration in the presence of obesity,
diabetes, and diabetes combined with neuropathy. A better
understanding of IMAT distribution within the calf will provide us with insight into muscles that may be more compromised by fatty infiltration and may lead to improved rehabilitation strategies in these populations.
Therefore, the purposes of this study were to determine
if IMAT accumulation is muscle specific, that is, determine
diﬀerence in IMAT volumes between individual muscles and
muscle compartments, if calf IMAT is diﬀerent between
groups of healthy obese people (HO), a group with diabetes
mellitus (D), and a group with diabetes and peripheral neuropathy (DN), if IMAT and/or the ratio of IMAT/muscle volume is related to function in these groups. We hypothesized
that the soleus muscle would display more IMAT than
the gastrocnemius muscle and all other calf compartments
across the three groups due to the predominance of slow
twitch fibers and higher lipid oxidation capacity in the soleus
muscle. Additionally, we hypothesized that the D and DN
groups would have greater volumes of IMAT in the calf, and
similar calf muscle volumes compared to the HO group, and
that the DN group would display the largest volume of calf
IMAT of all 3 groups. We hypothesized that calf IMAT volume would be inversely correlated with measures of physical
performance.

2. Methods and Procedures
2.1. Participants. Forty-five subjects participated in this
study (Table 1). The groups were matched for age and BMI.
Initially, there was an analysis of a group of 10 DN subjects
who best matched the 10 individuals in the other 2 groups.
However, this did not change the results and increased the
DN group variability. This led to reporting the larger group
of DN subjects.
Participants were recruited from the Washington University School of Medicine Diabetes Clinic, Washington University’s Volunteers for Health, the Center for Community
Based Research, and from diabetes clinics in the surrounding
St. Louis community. This study is part of a larger study
investigating the eﬀect of exercise for people with diabetes
and peripheral neuropathy. Participant characteristics are
listed in Table 1. Participants were excluded if they weighed
more than 300 pounds (equipment weight limit) or had
a history of severe foot deformity or amputation, any comorbidity or medications that would interfere with exercise
(such as severe rheumatoid arthritis, peripheral arterial disease (absent pulses), dialysis, or current cancer treatment).
Participants provided written informed consent. This study
was approved by the Human Research Protection Oﬃce at
Washington University in St. Louis.

3. Assessments
3.1. Peripheral Neuropathy. Presence of peripheral neuropathy was determined based on both an inability to feel
the 5.07 Semmes-Weinstein monofilament on at least one
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point on the plantar surface of the foot and on a vibration
perception threshold greater than 25 V as measured with a
biothesiometer applied to the plantar surface of the great toe
[11, 12]. All subjects were tested for presence of neuropathy;
to be included in the D and HO groups, subjects had to
be able to feel the 5.07 monofilament and have a vibration
perception threshold below 25 V.
3.2. Intermuscular Adipose Tissue (IMAT). Calf intermuscular adipose tissue volumes were quantified using MRI on the
right leg of each participant. The MRI scans were performed with the participant in a supine position with a Siemens
CP extremity coil placed over the right calf muscle. The
MRI measurements were performed with a 3.0 Tessla superconducting magnet with a pulse sequence of TE = 12 milliseconds, TR = 1, 500 milliseconds, matrix = 256 × 256;
both a fat-saturated and a non-fat-saturated image were collected [1]. Thirty transverse slices were collected beginning at
the joint space of the knee and proceeding distally. The slices
were 7 mm thick with no interslice gap. Nine consecutive
slices were selected to calculate muscle and IMAT volumes.
Volumes were quantified using a PC workstation and custom
Matlab software. The software uses voxel brightness to distinguish between muscle and adipose tissues [6, 13, 14]. The
subcutaneous adipose tissue was removed from each image
by drawing a line along the deep fascial plane surrounding
the calf muscle so that only the fat within and between the
muscles (IMAT) was remaining. The software uses edge detection algorithms to assist the user in separating the subcutaneous fat from the muscle as well as separating individual muscles and muscle compartments. In the calf, the
muscle was divided into (1) the anterior compartment, (2)
the lateral compartment, (3) the deep compartment, (4) the
gastrocnemius muscle, and (5) the soleus muscle (Figure 1).
Calf IMAT and calf muscle volumes are reported in cm3 .
An additional variable, IMAT per muscle volume, was also
used in analysis. Based on test-retest reliability of 21 subjects
(group included people who are obese, people with diabetes,
and people with diabetes and peripheral neuropathy), the
error in measuring muscle volume is less than 1% and less
than 2% for measuring fat volumes on average in any muscle
or compartment [15].
3.3. Six-Minute Walk Test. All participants performed the
six-minute walk test [16] which was validated previously in
obese adults [17]. The participants walked back and forth in
a hallway between 2 cones that were placed 100 feet (30.5 m)
apart. The participants were instructed that the goal was to
walk as far as possible in 6 minutes. Six-minute walk distance
was recorded as total distance walked (in meters).
3.4. Physical Performance Test (PPT). The modified 9-item
PPT was used to assess physical performance in all participants. This test is designed to mimic activities of daily
living, and the 9-item PPT has been shown to correlate well
with disability and frailty [18–20]. The 9-item PPT includes
placing a book on a shelf, putting a lab coat on and taking it
oﬀ, picking up a coin from the floor, a 25-foot walk down and
back at a fast speed, turning in a 360-degree circle, simulated
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Table 1: Subject demographics by group. Values are means (SD).

Group

N

Gender (M/F)

Age (years)

HO
D
DN

10
11
24

4/6
5/6
15/9

64 (9)
56 (9)
64 (13)

Diabetes medication
BMI (kg/m2 ) Weight (lbs) (oral only/insulin and HbA1c (%)
oral)
32.9 (4.6)
213 (41)
NA
5.8 (0.2)
35.5 (6.4)
226 (33)
6/5
8.1 (2.2)
32.6 (6.3)
217 (45)
13/11
7.1 (1.3)

DM duration (years)
NA
8.1 (6.9)
12.9 (9.0)

NA: not applicable.

(a)

(b)

(c)

Figure 1: (a) MRI image of calf with bone removed. (b) Subcutaneous adipose tissue removed. (c) Calf divided into 5 compartments
(anterior, lateral, deep, gastrocnemius, and soleus).

eating, writing a sentence, climbing a flight of stairs with 10
steps, and sitting to standing 5 times from a low chair. Each of
the items is scored on a scale of 0–4 based on the time it takes
to complete the task. Each task is performed twice, and the
average time is used to determine the 0–4 score. A maximum
score is indicated by a score of 36.
3.5. Stair Power Measure. Stair power (in watts) was calculated based on the time it took each participant to climb
a flight of 10 stairs as part of the PPT (average of 2 trials)
using the following formula which was adapted from the stair
sprinting power test [21]:

kgm
ftlbs
,
to
s
s

3.7. Statistical Methods. Statistical analyses were performed
using Systat for windows, version 13.0. An analysis of variance was used to examine the main and interaction eﬀects of
calf IMAT and muscle volumes (gastrocnemius, soleus, anterior compartment, lateral compartment, and deep compartment), group (HO, D, DN), and measures of physical performance. Post hoc t-tests were used to examine diﬀerences
in groups (HO, D, and DN) on the variables of calf IMAT
volume, calf muscle volumes, and physical performance as
needed based on the results of the ANOVA. A Pearson correlation was used to examine the associations between variables
across all 45 subjects—all scatter plots were inspected and
analyzed for outliers. Significance level was set at P = 0.05.

ftlbs
to Watts .
s

4. Results





Stair Power = 3.171 ∗ Weight kg /time (sec)
Climb avg ∗

1
1
∗
,
.1383
.7378

where 3.171 = distance traveled (m),
Climb avg = average time to

(1)

climb a flight of 10 stairs (sec),
1
= conversion
.1383
1
= conversion
.7378




3.6. Ankle Dorsiflexion and Plantarflexion Peak Torque and
Power. Concentric isokinetic ankle dorsiflexor and plantarflexor peak torque and power were assessed using a Biodex
Multijoint System 3 Pro isokinetic dynamometer. The tests
were performed at angular velocities of 60◦ /s. The average
power at 60◦ /s was determined by the time-averaged integrated area under the curve at the constant velocity of movement in the available range of motion [1]. All participants
were given 3 practice trials to ensure they were comfortable
with the test. The mean values for peak torque and average
power were calculated for 3 trials.





Subjects were allowed to touch a handrail for balance, but not
for pulling or pushing to ascend the stairs.

There were no group diﬀerences in age, BMI, or weight
(P > 0.05). The HO group was significantly diﬀerent from
the other groups in HbA1c and DM duration—the D and
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Table 2: ANOVA results: muscle morphology measures; all values are means (SD) in cm3 .

Muscle volume
IMAT volume
Anterior compartment muscle volume
Anterior compartment IMAT volume
Lateral compartment muscle volume
Lateral compartment IMAT volume
Deep compartment muscle volume
Deep compartment IMAT volume
Soleus muscle volume
Soleus IMAT volume
Gastroc. muscle volume
Gastroc. IMAT volume
IMAT/muscle volume

HO
404 (90)
67 (54)
62 (9)
7 (5)
36 (10)
6 (5)
51 (15)
9 (6)
127 (28)
14 (14)
128 (31)
31 (28)
0.144 (0.07)

D
434 (72)
65 (36)
69 (15)
10 (11)
38 (9)
5 (3)
54 (13)
8 (4)
130 (26)
14 (8)
142 (27)
27 (15)
0.158 (0.11)

DN
407 (88)
70 (40)
65 (14)
9 (5)
37 (11)
7 (4)
60 (12)
11 (5)
118 (32)
15 (10)
122 (40)
28 (21)
0.193 (0.16)

P values
0.65
0.94
0.57
0.53
0.85
0.62
0.15
0.23
0.46
0.97
0.35
0.90
0.58

Anterior compartment: comprised of tibialis anterior, extensor digitorum longus, and extensor hallucis longus muscles.
Lateral compartment: comprised of peroneus longus and brevis muscles.
Deep compartment: comprised of the tibialis posterior, flexor digitorum longus, and flexor hallucis longus muscles.

Table 3: ANOVA results: physical performance measures. Values
are means (SD).
HO
DFPT (Nm)
5.2 (4.3)
DFPOW (W)
2.3 (2.4)
PFPT (Nm)
58.0 (18.6)
PFPOW (W)
45.9 (15.1)
6 MW (m)
512.4 (48)a
PPT
34 (1.5)
Stair power (W) 808 (327)

D
15.3 (7.5)a
9.8 (6.6)a
48.1 (13.0)
38.7 (10.9)
459.6 (80)
31 (2.4)
671 (163)

DN
4.5 (5.3)
2.2 (3.2)
51.4 (16.5)
41.9 (18.1)
425.5 (98)
28 (4.0)
601 (226)

P values
0.00
0.00
0.37
0.38
0.04
0.001∗
0.04∗

∗

Indicates all 3 groups are diﬀerent.
that the group is diﬀerent from the other 2 groups.
DFPT: dorsiflexor peak torque; DFPOW: dorsiflexor power; PFPT: plantarflexor peak torque; PFPOW: plantarflexor power; 6 MW: six-minute walk
distance; PPT: physical performance test (9 items).
a Indicates

DN groups were not significantly diﬀerent on these measures. The gastrocnemius muscle had a higher ratio of IMAT/
muscle volume than any other muscle or compartment (P =
.005) across all participants (Table 2).
There were no group diﬀerences between any of the
calf muscle or IMAT volume measures (Table 2). Group
diﬀerences were determined for descriptive purposes and are
contained in Table 3.
Across all participants, calf IMAT volume was associated
with BMI (r = 0.31) and IMAT volume was associated
with poorer physical performance on the 6-minute walk test
(r = −0.47) and the physical performance test (r = −0.36).
IMAT/muscle volume was also associated with poor physical performance (PPT r = −0.44, 6 MW r = −0.48). Muscle
volume was not strongly associated with 6-minute walk distance or physical performance test score but was associated
with stair power (r = 0.51) (Table 4).

5. Discussion
This study is the first to report that the amount of IMAT/
muscle volume in the calf is muscle and compartment
specific in the pathologies of obesity, diabetes, and diabetes
combined with peripheral neuropathy. The gastrocnemius
muscle had the largest ratio of IMAT/muscle volume compared to any of the calf muscles and compartments, which
was contrary to what we expected and to what has been
reported in obese animal models [9, 10]. We speculate that
perhaps those muscles with a predominance of fast-twitch
fibers, such as the gastrocnemius muscle, are aﬀected by
IMAT accumulation preferentially or sequentially. The plantar flexor muscles are important for ankle stability, walking
velocity, and cadence [22]. Furthermore, the gastrocnemius
is used during powerful and phasic/burst type activity compared to the soleus muscle which is most active for postural
control. Perhaps the gastrocnemius is more aﬀected by IMAT
than the soleus muscle due to a greater reduction in power
activities compared to postural activities in these groups. Or,
perhaps the reduced lipid metabolism in the gastrocnemius
muscle compared to the soleus muscle results in greater
IMAT storage rather than lipid oxidation. Additional studies
are required to determine the underlying mechanisms for
the IMAT accumulation in the gastrocnemius muscle and its
propensity for having greater fat infiltration than other calf
muscles. Understanding the muscle specific distribution of
fat and the underlying mechanisms for fat infiltration may
lead to enhanced treatment strategies to improve the health
of the muscle and individual. For example, Marcus et al. [23]
demonstrated that people with type 2 diabetes were able to
improve performance, decrease fat, and increase lean tissue
in the thigh muscles after a 16-week exercise program that
included both aerobic and high-intensity eccentric exercise
training. Perhaps specific rehabilitation strategies that target
the gastrocnemius muscle could alter the fat infiltration and
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Table 4: Correlation matrix.

IMAT vol
BMI
IMAT vol
6 MW

∗

0.31

6 MW
−0.18
∗

−0.47

PPT

Stair POW

0.01

0.21
∗

Muscle Vol
0.49

∗

0.08

−0.36

−0.18

−0.32

0.93∗

0.79∗

0.58∗

0.25

−0.48∗

∗

0.24

−0.44∗

0.51∗

−0.30∗

PPT
Stair Pow
Muscle vol

0.60

∗

IMAT/Mus Vol

−0.35∗

∗ Indicates significance (P < 0.05).
IMAT: intermuscular adipose tissue volume; 6 MW: six-minute walk distance; PPT: physical performance test (9 items); Stair Pow: stair power; Muscle Vol:
calf muscle volume; IMAT/MusVol: ratio of IMAT/muscle volume in the calf.

improve deficits in muscle performance and physical performance.
Overall, the inverse correlation between calf IMAT volume and physical performance indicates that IMAT accumulation is associated with physical performance decline, but
it appears that there are other factors, such as the presence
of diabetes and/or neuropathy, that are key mediators of
physical performance. The ratio of IMAT/muscle volume was
inversely related to measures of muscle performance across
all subjects. The ratio of calf IMAT/muscle volume may be
an indicator of physical performance, but the IMAT/Muscle
volume does not diﬀer between those with diabetes and
diabetes and neuropathy compared to a healthy obese group
of subjects. These results are consistent with other reports
in the literature and suggest measures other than absolute
muscle volume or muscle cross-sectional area are needed to
completely characterize calf muscle composition and muscle
performance [1, 24] and suggest that perhaps IMAT/muscle
volume may be an indicator of “muscle quality.” These
data are also consistent with reports that people with D or
DN have limitations in physical performance and function
beyond what is fully explained by muscle changes alone [24,
25]. Certainly problems secondary to sensory neuropathy
can contribute to these deficits in physical performance [26].
We found, contrary to our expectations, that there were
no group diﬀerences in measures of IMAT volumes or
muscle volumes between a group with HO, a group with D,
and a group with DN. These results indicate that diabetes
and peripheral neuropathy were not associated with IMAT
accumulation in the calf beyond their association with BMI
in these groups of subjects. These results were surprising
because our previous study indicated that a group with
obesity, diabetes, and peripheral neuropathy had two times
the volume of IMAT compared to a nonobese, nondiabetic,
nonneuropathic control group [1]. Four of the six subjects
with DN in that group were sampled from a patient sample
with a history of foot ulcers rather than the community at
large, so it is likely that we were capturing a group with more
severe neuropathy in the previous study compared to what
we report here.
Of note, the HO group had an average HbA1c value of 5.8
which is indicative of people at risk for developing diabetes
[27]. This HbA1c value is consistent with other reports in
the literature that link IMAT with insulin resistance [5, 6],

and this marginally high HbA1c value could be a potential
indicator of those at risk for developing diabetes. Interestingly, the HO group had higher levels of physical performance than the D or DN groups, so perhaps an intervention
targeted at minimizing IMAT could diminish risk for developing diabetes and mitigate the functional decline that is associated with diabetes and diabetes and peripheral neuropathy.
There are limitations that should be considered. First, we
have a relatively small sample size. Based on the small eﬀect
size between groups, a post hoc power analysis revealed that
we would need to collect data on more than 3600 individuals
to be powered to find group diﬀerences in total IMAT in
the calf with a power of 0.80 and an alpha level at 0.05.
The magnitude and impact of IMAT accumulation in specific
calf muscles or compartments in people with severe diabetes
and peripheral neuropathy requires additional investigation.
We are limited in our ability to interpret results because we
do not have biopsies or other biochemical measures of the
individual muscles or adipose tissues to further elucidate
characteristics beyond our macroscopic MRI measures. This
study is also limited in that we do not have a measure of
activity level for each participant, so it is possible that our
groups could be diﬀerent from each other in levels of activity.
Future studies should characterize subjects on activity level,
activity types (endurance versus strengthening exercise), and
neuropathy severity to enhance interpretation of results.
We do not have electrodiagnostic measures of neuropathy,
and it possible that electrodiagnostic measures would have
provided us with a more accurate measure of neuropathy
severity including a measure of subclinical neuropathy in the
D or HO groups. Since the group with DN was originally
recruited for an exercise study, it is possible that we have
a selection bias towards people with DN who are higher
functioning. In addition, this group only had 2 people with a
history of plantar foot ulcer, so we do not believe these results
are generalizable to people with more severe complications
and longer durations of diabetes and peripheral neuropathy.
Lastly, the correlations between the diﬀerent variables only
indicate association and cannot determine cause and eﬀect.
In conclusion, this study found that increased calf IMAT
volume accumulation was muscle specific; the gastrocnemius
muscle had the largest ratio of IMAT/muscle volume of
all of the calf muscles and compartments. In addition, calf
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IMAT was associated with poorer physical performance. The
groups with D and DN had lower measures of physical performance than the HO group, suggesting that more severe
impairment in metabolic pathology, along with IMAT accumulation, impacts physical performance.
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